Clostridium News and Research

RSS

Study examines effect of low-dose vancomycin to treat clostridium difficile infection

Clostridium difficile infection (CDI) is inflammation of the colon caused by a bacteria called clostridium difficile and is the most common cause of infectious diarrhea in hospitalized patients.

8 Dec 2020

Clonal hematopoiesis linked to severe COVID-19

Now, an international team of researchers from the USA, South Korea and Canada has found that clonal hematopoiesis is tied to the risk of severe COVID-19.

30 Nov 2020

Researchers use genomic tools and supercomputers to study the infant gut microbiome

Since 2017, University of Alabama at Birmingham researchers Casey Morrow, Ph.D., and Hyunmin Koo, Ph.D., have used powerful genomic tools and supercomputers that analyze massive amounts of genetic data to identify individual strains within single species of the gut microbiome.

29 Oct 2020

Fecal microbiota transplantation restores gut microbial development in cesarean-born infants

The human gut contains a diverse ecosystem of microbes: mainly bacteria, as well as viruses and fungi, termed the gut microbiota. Recent years have shown that the gut microbiota have widespread effects on the overall functioning of the host's body.

1 Oct 2020

New AGA report details effectiveness and safety of fecal microbiota transplantation

Today, the American Gastroenterological Association released the first results from the NIH-funded AGA Fecal Microbiota Transplantation National Registry, the largest real-world study on the safety and effectiveness of FMT.

1 Oct 2020

Researchers identify pathogen responsible for creeping migration of fat in Crohn's patients

In many patients with Crohn's disease, abdominal fat migrates to the wall of the inflamed small intestines. What prompts the fat tissue to "creep" through the abdomen and wrap around the intestines of many patients with this inflammatory bowel disease (IBD) has been an enduring mystery.

1 Oct 2020

Gut microbiome may play a part in severe COVID-19

A recent study published on the preprint medRxiv* in August 2020 reports on the evidence that the gut microbiome may play a part in severe COVID-19 infection.

19 Aug 2020

LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

Today, LGC announced the acquisition of The Native Antigen Company (NAC), one of the world’s leading suppliers of high quality infectious disease antigens and antibodies.

9 Jul 2020

Easy-to-use software developed to identify drug-resistant genes in bacteria

Washington State University researchers have developed an easy-to-use software program to identify drug-resistant genes in bacteria.

6 Jul 2020

Fecal microbial transplantation more effective, cost-efficient treatment than antibiotics

An innovative treatment for patients with Clostridium difficile infection (CDI) which uses transplanted gut bacteria to treat the infection, is a more effective and more cost-efficient treatment than using antibiotics, a new UK study has found.

29 Jun 2020

Researchers decipher deadly bacterial infection in pigs

The Clostridium perfringens bacterium is part of the large Clostridium genus which can cause various fatal illnesses in animals and humans.

4 Jun 2020

Study summarizes new evidence on using probiotics for specific health conditions

Probiotic supplements are widely available and are sometimes promoted as a general way to support gut microbiome and promote health.

1 Jun 2020

Vaginal bacteria linked to premature birth

A new study published in the journal Frontiers in Microbiology in April 2020 reports that women who deliver early are more likely to have a greater variety of bacteria in their birth canals. The research also highlights specific bacteria that are associated with premature birth. This knowledge could help design tests to screen for high-risk pregnancies.

8 Apr 2020

Artificial Intelligence brings a novel antibiotic compound

Researchers from the Massachusetts Institute of Technology (MIT) have made a scientific breakthrough where their machine-learning algorithm or Artificial Intelligence (AI) program successfully created a novel antibiotic compound. The drug has since then been tested on deadly bacteria in the lab, and in lab mice with a considerable amount of success, explain the researchers. The study results appear in the latest issue of the journal Cell.

20 Feb 2020

Diets high in fat and protein exacerbate C. diff infections in mice

Popular diets low in carbs and high in fat and protein might be good for the waistline, but a new UNLV study shows that just the opposite may help to alleviate the hospital-acquired infection Clostridioides difficile.

12 Feb 2020

Fly model could help lay the foundation for new therapies to fight 'difficult' pathogen

The Clostridium difficile pathogen takes its name from the French word for "difficult." A bacterium that is known to cause symptoms ranging from diarrhea to life-threatening colon damage, C. difficile is part of a growing epidemic of concern for the elderly and patients on antibiotics.

8 Feb 2020

New findings can help develop more effective antibiotic treatments to fight superbugs

Researchers have found how an antibiotic used to treat a debilitating gut infection stays put inside the body giving it time to effectively treat the problem, a discovery that will pave the way for the development of more effective antibiotic treatments to fight superbugs.

22 Jan 2020

Study: Environment changes can impact stability landscape of the gut microbial community

Your fingerprints stay the same all your life. But what about the "fingerprint" of microbial strains that are shared in the guts of childhood twins?

9 Jan 2020

Structure of most lethal toxin produced by C. difficile bacteria identified

Researchers from the University of Maryland School of Medicine and their colleagues have identified the structure of the most lethal toxin produced by certain strains of Clostridium difficile bacteria, a potentially deadly infection associated with the use of antibiotics. The

2 Jan 2020

People who eat bushmeat may be at risk of contracting life-threatening diseases

People who eat wildebeests, wart hogs and other wild African animals may be at risk for contracting potentially life-threatening diseases, according to an international team of researchers.

2 Dec 2019

Clostridium News and Research

Study examines effect of low-dose vancomycin to treat clostridium difficile infection

Clonal hematopoiesis linked to severe COVID-19

Researchers use genomic tools and supercomputers to study the infant gut microbiome

Fecal microbiota transplantation restores gut microbial development in cesarean-born infants

New AGA report details effectiveness and safety of fecal microbiota transplantation

Researchers identify pathogen responsible for creeping migration of fat in Crohn's patients

Gut microbiome may play a part in severe COVID-19

LGC acquires The Native Antigen Company, strengthening its offer to the IVD sector

Easy-to-use software developed to identify drug-resistant genes in bacteria

Fecal microbial transplantation more effective, cost-efficient treatment than antibiotics

Researchers decipher deadly bacterial infection in pigs

Study summarizes new evidence on using probiotics for specific health conditions

Vaginal bacteria linked to premature birth

Artificial Intelligence brings a novel antibiotic compound

Diets high in fat and protein exacerbate C. diff infections in mice

Fly model could help lay the foundation for new therapies to fight 'difficult' pathogen

New findings can help develop more effective antibiotic treatments to fight superbugs

Study: Environment changes can impact stability landscape of the gut microbial community

Structure of most lethal toxin produced by C. difficile bacteria identified

People who eat bushmeat may be at risk of contracting life-threatening diseases

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News